Balchem Corporation Acquires Bioscreen Technologies, S.r.l.
August 29 2018 - 4:15PM
Balchem Corporation (NASDAQ:BCPC), through its wholly owned
subsidiary, Balchem Italia S.r.l., today acquired Bioscreen
Technologies, S.r.l., a small privately held manufacturer of
encapsulated and fermented feed nutrition ingredients,
headquartered in Bertinoro, Italy. The financial terms of the
transaction were not disclosed.
Bioscreen manufactures high-performance
encapsulates and fermented products that deliver value-added
solutions to an international animal nutrition and health customer
base. Launched in 2005, Bioscreen has focused on developing and
marketing new and improved technologies to meet customer needs.
Bioscreen’s existing business will be integrated
within Balchem’s Animal Nutrition & Health business segment.
The Animal Nutrition & Health segment provides a growing
portfolio of encapsulated nutrients, choline products and chelated
minerals including ReaShure®, NitroShureTM, AminoShure®,
NiaShureTM, PetShureTM and KeyShure®. With a focus on improving
productivity and profitability, this segment is leading the charge
to meet the nutritional needs of ruminants, monogastrics and
companion animals.
“We are very excited to bring Bioscreen’s
manufacturing, technical and commercial capabilities into our
company. While Bioscreen does not bring significant existing
business to Balchem, this acquisition provides a European
manufacturing platform for Balchem’s encapsulated nutrients and
will allow us to accelerate our growth within Europe,” said
Jonathan Griffin, Vice President and General Manager, Animal
Nutrition & Health.
Griffin added, “The addition of local European
manufacturing capabilities for our encapsulated products, to our
existing European Choline manufacturing footprint, further
strengthens our ability to bring a broad range of health and
nutrition solutions to our European customers.”
Segment InformationBalchem
Corporation reports four business segments: Human Nutrition &
Health; Animal Nutrition & Health; Specialty Products; and
Industrial Products. The Human Nutrition & Health segment
delivers customized food and beverage ingredient systems, as well
as key nutrients into a variety of applications across the food,
supplement and pharmaceutical industries. The Animal Nutrition
& Health segment manufactures and supplies products to numerous
animal health markets. Through Specialty Products, Balchem provides
specialty-packaged chemicals for use in healthcare and other
industries, and also provides chelated minerals to the
micronutrient agricultural market. The Industrial Products segment
manufactures and supplies certain derivative products into
industrial applications.
Forward-Looking StatementsThis
release contains forward-looking statements, which reflect
Balchem’s expectation or belief concerning future events that
involve risks and uncertainties. Balchem can give no assurance that
the expectations reflected in forward-looking statements will prove
correct and various factors could cause results to differ
materially from Balchem’s expectations, including risks and factors
identified in Balchem’s annual report on Form 10-K for the year
ended December 31, 2017. Forward-looking statements are qualified
in their entirety by the above cautionary statement. Balchem
assumes no duty to update its outlook or other forward-looking
statements as of any future date.
Contact:
Terry Coelho, Balchem Corporation(845) 326-5600
/ tcoelho@balchem.com
Balchem (NASDAQ:BCPC)
Historical Stock Chart
From Mar 2024 to Apr 2024
Balchem (NASDAQ:BCPC)
Historical Stock Chart
From Apr 2023 to Apr 2024